Global Genetically Engineered Vector Vaccine Supply, Demand and Key Producers, 2024-2030

Publication ID:

GIR032416797

Publication Date:

April 8, 2024

Pages:

172

Publisher:

GIR

Countries:

Global [1]

USD 4,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Genetically Engineered Vector Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
A genetically engineered vector vaccine is a type of vaccine that uses a viral vector that has been genetically modified to carry and express genes encoding antigens from a pathogen, such as a virus or bacterium. This approach is part of the broader field of genetic engineering in vaccinology and is designed to stimulate an immune response against the target pathogen.
This report studies the global Genetically Engineered Vector Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Genetically Engineered Vector Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genetically Engineered Vector Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Genetically Engineered Vector Vaccine total production and demand, 2019-2030, (K Units)
Global Genetically Engineered Vector Vaccine total production value, 2019-2030, (USD Million)
Global Genetically Engineered Vector Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Genetically Engineered Vector Vaccine consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Genetically Engineered Vector Vaccine domestic production, consumption, key domestic manufacturers and share
Global Genetically Engineered Vector Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Genetically Engineered Vector Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Genetically Engineered Vector Vaccine production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Genetically Engineered Vector Vaccine market based on the following parameters 鈥� company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Merck, GSK, Wantai Biotechnology, Watson Bio, Bharat Biotech, Sanofi, Zoties and Elanco, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Genetically Engineered Vector Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Genetically Engineered Vector Vaccine 麻豆原创, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Genetically Engineered Vector Vaccine 麻豆原创, Segmentation by Type
Viral Vector Vaccine
Plasmid Vector Vaccine
VLPV
RNA Vaccine
Global Genetically Engineered Vector Vaccine 麻豆原创, Segmentation by Application
Hospital
Clinic
Others
Companies Profiled:
Pfizer
Merck
GSK
Wantai Biotechnology
Watson Bio
Bharat Biotech
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
Zhongmu Industrial Co., Ltd.
Qingdao Yibang Bioengineering Co., Ltd.
Jinyu Biotechnology
Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences
Tianjin Ruipu Biotechnology
Kyoto Biken Laboratories
FATRO
Ceva Sant茅 Animale
Pleco
Wuhan Huisheng Biotechnology
Jinhe Biotechnology
Shenlian Biotechnology
Azure Creatures
Key Questions Answered
1. How big is the global Genetically Engineered Vector Vaccine market?
2. What is the demand of the global Genetically Engineered Vector Vaccine market?
3. What is the year over year growth of the global Genetically Engineered Vector Vaccine market?
4. What is the production and production value of the global Genetically Engineered Vector Vaccine market?
5. Who are the key producers in the global Genetically Engineered Vector Vaccine market?

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 Supply Summary
1.1 Genetically Engineered Vector Vaccine Introduction
1.2 World Genetically Engineered Vector Vaccine Supply & Forecast
1.2.1 World Genetically Engineered Vector Vaccine Production Value (2019 & 2023 & 2030)
1.2.2 World Genetically Engineered Vector Vaccine Production (2019-2030)
1.2.3 World Genetically Engineered Vector Vaccine Pricing Trends (2019-2030)
1.3 World Genetically Engineered Vector Vaccine Production by Region (Based on Production Site)
1.3.1 World Genetically Engineered Vector Vaccine Production Value by Region (2019-2030)
1.3.2 World Genetically Engineered Vector Vaccine Production by Region (2019-2030)
1.3.3 World Genetically Engineered Vector Vaccine Average Price by Region (2019-2030)
1.3.4 North America Genetically Engineered Vector Vaccine Production (2019-2030)
1.3.5 Europe Genetically Engineered Vector Vaccine Production (2019-2030)
1.3.6 China Genetically Engineered Vector Vaccine Production (2019-2030)
1.3.7 Japan Genetically Engineered Vector Vaccine Production (2019-2030)
1.4 麻豆原创 Drivers, Restraints and Trends
1.4.1 Genetically Engineered Vector Vaccine 麻豆原创 Drivers
1.4.2 Factors Affecting Demand
1.4.3 Genetically Engineered Vector Vaccine Major 麻豆原创 Trends
2 Demand Summary
2.1 World Genetically Engineered Vector Vaccine Demand (2019-2030)
2.2 World Genetically Engineered Vector Vaccine Consumption by Region
2.2.1 World Genetically Engineered Vector Vaccine Consumption by Region (2019-2024)
2.2.2 World Genetically Engineered Vector Vaccine Consumption Forecast by Region (2025-2030)
2.3 United States Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.4 China Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.5 Europe Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.6 Japan Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.7 South Korea Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.8 ASEAN Genetically Engineered Vector Vaccine Consumption (2019-2030)
2.9 India Genetically Engineered Vector Vaccine Consumption (2019-2030)
3 World Genetically Engineered Vector Vaccine Manufacturers Competitive Analysis
3.1 World Genetically Engineered Vector Vaccine Production Value by Manufacturer (2019-2024)
3.2 World Genetically Engineered Vector Vaccine Production by Manufacturer (2019-2024)
3.3 World Genetically Engineered Vector Vaccine Average Price by Manufacturer (2019-2024)
3.4 Genetically Engineered Vector Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Genetically Engineered Vector Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Genetically Engineered Vector Vaccine in 2023
3.5.3 Global Concentration Ratios (CR8) for Genetically Engineered Vector Vaccine in 2023
3.6 Genetically Engineered Vector Vaccine 麻豆原创: Overall Company Footprint Analysis
3.6.1 Genetically Engineered Vector Vaccine 麻豆原创: Region Footprint
3.6.2 Genetically Engineered Vector Vaccine 麻豆原创: Company Product Type Footprint
3.6.3 Genetically Engineered Vector Vaccine 麻豆原创: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of 麻豆原创 Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Genetically Engineered Vector Vaccine Production Value Comparison
4.1.1 United States VS China: Genetically Engineered Vector Vaccine Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Genetically Engineered Vector Vaccine Production Value 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Genetically Engineered Vector Vaccine Production Comparison
4.2.1 United States VS China: Genetically Engineered Vector Vaccine Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Genetically Engineered Vector Vaccine Production 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Genetically Engineered Vector Vaccine Consumption Comparison
4.3.1 United States VS China: Genetically Engineered Vector Vaccine Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Genetically Engineered Vector Vaccine Consumption 麻豆原创 Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Genetically Engineered Vector Vaccine Manufacturers and 麻豆原创 Share, 2019-2024
4.4.1 United States Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Genetically Engineered Vector Vaccine Production Value (2019-2024)
4.4.3 United States Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024)
4.5 China Based Genetically Engineered Vector Vaccine Manufacturers and 麻豆原创 Share
4.5.1 China Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Genetically Engineered Vector Vaccine Production Value (2019-2024)
4.5.3 China Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024)
4.6 Rest of World Based Genetically Engineered Vector Vaccine Manufacturers and 麻豆原创 Share, 2019-2024
4.6.1 Rest of World Based Genetically Engineered Vector Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Genetically Engineered Vector Vaccine Production (2019-2024)
5 麻豆原创 Analysis by Type
5.1 World Genetically Engineered Vector Vaccine 麻豆原创 Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Viral Vector Vaccine
5.2.2 Plasmid Vector Vaccine
5.2.3 VLPV
5.2.4 RNA Vaccine
5.3 麻豆原创 Segment by Type
5.3.1 World Genetically Engineered Vector Vaccine Production by Type (2019-2030)
5.3.2 World Genetically Engineered Vector Vaccine Production Value by Type (2019-2030)
5.3.3 World Genetically Engineered Vector Vaccine Average Price by Type (2019-2030)
6 麻豆原创 Analysis by Application
6.1 World Genetically Engineered Vector Vaccine 麻豆原创 Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 麻豆原创 Segment by Application
6.3.1 World Genetically Engineered Vector Vaccine Production by Application (2019-2030)
6.3.2 World Genetically Engineered Vector Vaccine Production Value by Application (2019-2030)
6.3.3 World Genetically Engineered Vector Vaccine Average Price by Application (2019-2030)
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Genetically Engineered Vector Vaccine Product and Services
7.1.4 Pfizer Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Genetically Engineered Vector Vaccine Product and Services
7.2.4 Merck Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Genetically Engineered Vector Vaccine Product and Services
7.3.4 GSK Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Wantai Biotechnology
7.4.1 Wantai Biotechnology Details
7.4.2 Wantai Biotechnology Major Business
7.4.3 Wantai Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.4.4 Wantai Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.4.5 Wantai Biotechnology Recent Developments/Updates
7.4.6 Wantai Biotechnology Competitive Strengths & Weaknesses
7.5 Watson Bio
7.5.1 Watson Bio Details
7.5.2 Watson Bio Major Business
7.5.3 Watson Bio Genetically Engineered Vector Vaccine Product and Services
7.5.4 Watson Bio Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.5.5 Watson Bio Recent Developments/Updates
7.5.6 Watson Bio Competitive Strengths & Weaknesses
7.6 Bharat Biotech
7.6.1 Bharat Biotech Details
7.6.2 Bharat Biotech Major Business
7.6.3 Bharat Biotech Genetically Engineered Vector Vaccine Product and Services
7.6.4 Bharat Biotech Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.6.5 Bharat Biotech Recent Developments/Updates
7.6.6 Bharat Biotech Competitive Strengths & Weaknesses
7.7 Sanofi
7.7.1 Sanofi Details
7.7.2 Sanofi Major Business
7.7.3 Sanofi Genetically Engineered Vector Vaccine Product and Services
7.7.4 Sanofi Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.7.5 Sanofi Recent Developments/Updates
7.7.6 Sanofi Competitive Strengths & Weaknesses
7.8 Zoties
7.8.1 Zoties Details
7.8.2 Zoties Major Business
7.8.3 Zoties Genetically Engineered Vector Vaccine Product and Services
7.8.4 Zoties Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.8.5 Zoties Recent Developments/Updates
7.8.6 Zoties Competitive Strengths & Weaknesses
7.9 Elanco
7.9.1 Elanco Details
7.9.2 Elanco Major Business
7.9.3 Elanco Genetically Engineered Vector Vaccine Product and Services
7.9.4 Elanco Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.9.5 Elanco Recent Developments/Updates
7.9.6 Elanco Competitive Strengths & Weaknesses
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Details
7.10.2 Boehringer Ingelheim Major Business
7.10.3 Boehringer Ingelheim Genetically Engineered Vector Vaccine Product and Services
7.10.4 Boehringer Ingelheim Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.10.5 Boehringer Ingelheim Recent Developments/Updates
7.10.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.11 Indian Immunologicals
7.11.1 Indian Immunologicals Details
7.11.2 Indian Immunologicals Major Business
7.11.3 Indian Immunologicals Genetically Engineered Vector Vaccine Product and Services
7.11.4 Indian Immunologicals Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.11.5 Indian Immunologicals Recent Developments/Updates
7.11.6 Indian Immunologicals Competitive Strengths & Weaknesses
7.12 Zhongmu Industrial Co., Ltd.
7.12.1 Zhongmu Industrial Co., Ltd. Details
7.12.2 Zhongmu Industrial Co., Ltd. Major Business
7.12.3 Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Product and Services
7.12.4 Zhongmu Industrial Co., Ltd. Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.12.5 Zhongmu Industrial Co., Ltd. Recent Developments/Updates
7.12.6 Zhongmu Industrial Co., Ltd. Competitive Strengths & Weaknesses
7.13 Qingdao Yibang Bioengineering Co., Ltd.
7.13.1 Qingdao Yibang Bioengineering Co., Ltd. Details
7.13.2 Qingdao Yibang Bioengineering Co., Ltd. Major Business
7.13.3 Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Product and Services
7.13.4 Qingdao Yibang Bioengineering Co., Ltd. Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.13.5 Qingdao Yibang Bioengineering Co., Ltd. Recent Developments/Updates
7.13.6 Qingdao Yibang Bioengineering Co., Ltd. Competitive Strengths & Weaknesses
7.14 Jinyu Biotechnology
7.14.1 Jinyu Biotechnology Details
7.14.2 Jinyu Biotechnology Major Business
7.14.3 Jinyu Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.14.4 Jinyu Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.14.5 Jinyu Biotechnology Recent Developments/Updates
7.14.6 Jinyu Biotechnology Competitive Strengths & Weaknesses
7.15 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences
7.15.1 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Details
7.15.2 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Major Business
7.15.3 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Product and Services
7.15.4 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.15.5 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Recent Developments/Updates
7.15.6 Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences Competitive Strengths & Weaknesses
7.16 Tianjin Ruipu Biotechnology
7.16.1 Tianjin Ruipu Biotechnology Details
7.16.2 Tianjin Ruipu Biotechnology Major Business
7.16.3 Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.16.4 Tianjin Ruipu Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.16.5 Tianjin Ruipu Biotechnology Recent Developments/Updates
7.16.6 Tianjin Ruipu Biotechnology Competitive Strengths & Weaknesses
7.17 Kyoto Biken Laboratories
7.17.1 Kyoto Biken Laboratories Details
7.17.2 Kyoto Biken Laboratories Major Business
7.17.3 Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Product and Services
7.17.4 Kyoto Biken Laboratories Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.17.5 Kyoto Biken Laboratories Recent Developments/Updates
7.17.6 Kyoto Biken Laboratories Competitive Strengths & Weaknesses
7.18 FATRO
7.18.1 FATRO Details
7.18.2 FATRO Major Business
7.18.3 FATRO Genetically Engineered Vector Vaccine Product and Services
7.18.4 FATRO Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.18.5 FATRO Recent Developments/Updates
7.18.6 FATRO Competitive Strengths & Weaknesses
7.19 Ceva Sant茅 Animale
7.19.1 Ceva Sant茅 Animale Details
7.19.2 Ceva Sant茅 Animale Major Business
7.19.3 Ceva Sant茅 Animale Genetically Engineered Vector Vaccine Product and Services
7.19.4 Ceva Sant茅 Animale Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.19.5 Ceva Sant茅 Animale Recent Developments/Updates
7.19.6 Ceva Sant茅 Animale Competitive Strengths & Weaknesses
7.20 Pleco
7.20.1 Pleco Details
7.20.2 Pleco Major Business
7.20.3 Pleco Genetically Engineered Vector Vaccine Product and Services
7.20.4 Pleco Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.20.5 Pleco Recent Developments/Updates
7.20.6 Pleco Competitive Strengths & Weaknesses
7.21 Wuhan Huisheng Biotechnology
7.21.1 Wuhan Huisheng Biotechnology Details
7.21.2 Wuhan Huisheng Biotechnology Major Business
7.21.3 Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.21.4 Wuhan Huisheng Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.21.5 Wuhan Huisheng Biotechnology Recent Developments/Updates
7.21.6 Wuhan Huisheng Biotechnology Competitive Strengths & Weaknesses
7.22 Jinhe Biotechnology
7.22.1 Jinhe Biotechnology Details
7.22.2 Jinhe Biotechnology Major Business
7.22.3 Jinhe Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.22.4 Jinhe Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.22.5 Jinhe Biotechnology Recent Developments/Updates
7.22.6 Jinhe Biotechnology Competitive Strengths & Weaknesses
7.23 Shenlian Biotechnology
7.23.1 Shenlian Biotechnology Details
7.23.2 Shenlian Biotechnology Major Business
7.23.3 Shenlian Biotechnology Genetically Engineered Vector Vaccine Product and Services
7.23.4 Shenlian Biotechnology Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.23.5 Shenlian Biotechnology Recent Developments/Updates
7.23.6 Shenlian Biotechnology Competitive Strengths & Weaknesses
7.24 Azure Creatures
7.24.1 Azure Creatures Details
7.24.2 Azure Creatures Major Business
7.24.3 Azure Creatures Genetically Engineered Vector Vaccine Product and Services
7.24.4 Azure Creatures Genetically Engineered Vector Vaccine Production, Price, Value, Gross Margin and 麻豆原创 Share (2019-2024)
7.24.5 Azure Creatures Recent Developments/Updates
7.24.6 Azure Creatures Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Genetically Engineered Vector Vaccine Industry Chain
8.2 Genetically Engineered Vector Vaccine Upstream Analysis
8.2.1 Genetically Engineered Vector Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Genetically Engineered Vector Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Genetically Engineered Vector Vaccine Production Mode
8.6 Genetically Engineered Vector Vaccine Procurement Model
8.7 Genetically Engineered Vector Vaccine Industry Sales Model and Sales Channels
8.7.1 Genetically Engineered Vector Vaccine Sales Model
8.7.2 Genetically Engineered Vector Vaccine Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

Companies Mentioned:

Pfizer
Merck
GSK
Wantai Biotechnology
Watson Bio
Bharat Biotech
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
Zhongmu Industrial Co., Ltd.
Qingdao Yibang Bioengineering Co., Ltd.
Jinyu Biotechnology
Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences
Tianjin Ruipu Biotechnology
Kyoto Biken Laboratories
FATRO
Ceva Sant茅 Animale
Pleco
Wuhan Huisheng Biotechnology
Jinhe Biotechnology
Shenlian Biotechnology
Azure Creatures

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.